PT-141 (Bremelanotide)
sexual health fertility
Dosing Schedule (Subcutaneous)
| Use Case | Dose (mcg) |  Log Doses |
|---|---|---|
| Standard (FDA-approved) | 1750 mcg (1.75 mg) | + Log |
| Lower Starting Dose | 1000 mcg (1.0 mg) | + Log |
| Conservative Start | 500 mcg (0.5 mg) | + Log |
Frequency: No more than once every 24 hours.
Timing: At least 45 minutes before anticipated sexual activity.
Cycle Length: Use as needed; maximum of 8 doses per month is standard in clinical settings.
Need PT-141 (Bremelanotide)?
Lab-tested research peptides from N1 Aminos